DRAK2 suppresses autophagy by phosphorylating ULK1 at Ser 56 to diminish pancreatic β cell function upon overnutrition
Science Translational Medicine · 2024
DOI: 10.1126/scitranslmed.ade8647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2024. Verfasst von Yuting Lu und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Sha…. Hauptthemen laut MEDLINE: Autophagy-Related Protein-1 Homolog, Diabetes Mellitus, Type 2, Insulin-Secreting Cells, Overnutrition. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Impeded autophagy can impair pancreatic β cell function by causing apoptosis, of which DAP-related apoptosis-inducing kinase-2 (DRAK2) is a critical regulator. Here, we identified a marked up-regulation of DRAK2 in pancreatic tissue across humans, macaques, and mice with type 2 diabetes (T2D). Further studies in mice showed that conditional knockout (cKO) of DRAK2 in pancreatic β cells protected β cell function against high-fat diet feeding along with sustained autophagy and mitochondrial function. Phosphoproteome analysis in isolated mouse primary islets revealed that DRAK2 directly phosphorylated unc-51–like autophagy activating kinase 1 (ULK1) at Ser 56 , which was subsequently found to induce ULK1 ubiquitylation and suppress autophagy. ULK1-S56A mutation or pharmacological inhibition of DRAK2 preserved mitochondrial function and insulin secretion against lipotoxicity in mouse primary islets, Min6 cells, or INS-1E cells. In conclusion, these findings together indicate an indispensable role of the DRAK2-ULK1 axis in pancreatic β cells upon metabolic challenge, which offers a potential target to protect β cell function in T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Shanghai, 201203, P. R. China.
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, Guangdong 528400, P. R. China.
- Department of Pathology and Pathophysiology and Department of Cardiology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, P. R. China.
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, P. R. China.
- University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
- Shanghai Jiaotong University, School of Medicine, Renji Hospital, Shanghai, 201112, P. R. China.
ORCID-Profile: Yuting Lu, Junyu Xu, Yufeng Li, Ruoran Wang, Chengqiu Dai, Bingqian Zhang, Xinwen Zhang, Lei Xu, Yunhua Tao, Ming Han, Ren Guo, Qingqian Wu, Linshi Wu, Zhuoxian Meng, Minjia Tan, Jingya Li
Zitieren
APA
Lu, Y., Xu, J., Li, Y., Wang, R., Dai, C., Zhang, B., Zhang, X., Xu, L., Tao, Y., Han, M., Guo, R., Wu, Q., Wu, L., Meng, Z., Tan, M., & Li, J. (2024). DRAK2 suppresses autophagy by phosphorylating ULK1 at Ser 56 to diminish pancreatic β cell function upon overnutrition. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ade8647
Vancouver
Lu Y, Xu J, Li Y, Wang R, Dai C, Zhang B, et al. DRAK2 suppresses autophagy by phosphorylating ULK1 at Ser 56 to diminish pancreatic β cell function upon overnutrition. Science Translational Medicine. 2024. doi:10.1126/scitranslmed.ade8647
BibTeX
@article{Lu2024,
author = {Lu, Yuting and Xu, Junyu and Li, Yufeng and Wang, Ruoran and Dai, Chengqiu and Zhang, Bingqian and Zhang, Xinwen and Xu, Lei and Tao, Yunhua and Han, Ming and Guo, Ren and Wu, Qingqian and Wu, Linshi and Meng, Zhuoxian and Tan, Minjia and Li, Jingya},
title = {DRAK2 suppresses autophagy by phosphorylating ULK1 at Ser 56 to diminish pancreatic β cell function upon overnutrition},
journal = {Science Translational Medicine},
year = {2024},
doi = {10.1126/scitranslmed.ade8647}
}
EUVIMED